Chromosomal integration of adenoviral vector DNA in vivo

Journal of Virology

Volumn 84, Issue 19, 2010, Pages 9987-9994

  Stephen, Sam Laurel ^a,e   Montini, Eugenio ^b,f   Sivanandam, Vijayshankar Ganesh ^a,g   Al Dhalimy, Muhseen ^b   Kestler, Hans A ^d   Finegold, Milton ^c   Grompe, Markus ^b   Kochanek, Stefan ^a,d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF ULM   (Germany)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^g UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; EXTRACHROMOSOMAL DNA; FUMARYLACETOACETASE; GENOMIC DNA; HYDROLASE; PRIMER DNA; RECOMBINANT PROTEIN; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DNA VECTOR; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GENE LOCUS; GENE TRANSFER; HOMOLOGOUS RECOMBINATION; IN VIVO STUDY; LIVER CELL; LIVER NODULE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; ADENOVIRIDAE; ANIMAL; CHROMOSOME; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; NUCLEOTIDE SEQUENCE; TRANSGENIC MOUSE; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

ADENOVIRIDAE;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; CHROMOSOMES; DNA PRIMERS; DNA, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HYDROLASES; LIVER; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; VIRUS INTEGRATION;

EID: 77956839837     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00751-10     Document Type: Article

References (48)

1. Beard, B. C., K. A. Keyser, G. D. Trobridge, L. J. Peterson, D. G. Miller, M. Jacobs, R. Kaul, and H. P. Kiem. 2007. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus. Hum. Gene Ther. 18:423-434.
2. Bushman, F., M. Lewinski, A. Ciuffi, S. Barr, J. Leipzig, S. Hannenhalli, and C. Hoffmann. 2005. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3:848-858.
3. Doerfler, W. 2006. De novo methylation, long-term promoter silencing, methylation patterns in the human genome, and consequences of foreign DNA insertion. Curr. Top. Microbiol. Immunol. 301:125-175.
4. Doerfler, W. 1968. The fate of the DNA of adenovirus type 12 in baby hamster kidney cells. Proc. Natl. Acad. Sci. U. S. A. 60:636-643.
5. Doerfler, W., H. Burger, J. Ortin, E. Fanning, D. T. Brown, M. Mestphal, U. Winterhoff, B. Weiser, and J. Schick. 1975. Integration of adenovirus DNA into the cellular genome. Cold Spring Harbor Symp. Quant. Biol. 39 (Pt 1):505-521.
6. Doerfler, W., R. Gahlmann, S. Stabel, R. Deuring, U. Lichtenberg, M. Schulz, D. Eick, and R. Leisten. 1984. On the mechanism of recombination between adenoviral and cellular DNAs: the structure of junction sites. Curr. Top. Microbiol. Immunol. 109:193-228.
7. Drake, J. W., B. Charlesworth, D. Charlesworth, and J. F. Crow. 1998. Rates of spontaneous mutation. Genetics 148:1667-1686.
8. Grompe, M., M. al-Dhalimy, M. Finegold, C. N. Ou, T. Burlingame, N. G. Kennaway, and P. Soriano. 1993. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev. 7:2298-2307.
9. Hacein-Bey-Abina, S., C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J. L. Villeval, C. C. Fraser, M. Cavazzana-Calvo, and A. Fischer. 2003. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348:255-256.
10. Hacein-Bey-Abina, S., C. Von Kalle, M. Schmidt, M. P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J. I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L. E. Leiva, M. Wissler, C. Prinz, T. H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419. (Pubitemid 37296260)
11. Hagan, J. P., and C. M. Croce. 2007. MicroRNAs in carcinogenesis. Cytogenet. Genome Res. 118:252-259.
12. Harui, A., S. Suzuki, S. Kochanek, and K. Mitani. 1999. Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 73:6141-6146.
13. Held, P. K., E. C. Olivares, C. P. Aguilar, M. Finegold, M. P. Calos, and M. Grompe. 2005. In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery. Mol. Ther. 11:399-408.
14. Hillgenberg, M., H. Tonnies, and M. Strauss. 2001. Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer. J. Virol. 75:9896-9908.
15. Hohlweg, U., M. Hosel, A. Dorn, D. Webb, K. Hilger-Eversheim, R. Remus, B. Schmitz, R. Buettner, A. Schramme, L. Corzilius, A. Niemann, and W. Doerfler. 2003. Intraperitoneal dissemination of Ad12-induced undifferentiated neuroectodermal hamster tumors: de novo methylation and transcription patterns of integrated viral and of cellular genes. Virus Res. 98:45-56. (Pubitemid 37377926)
16. International Human Genome Sequencing Consortium. 2004. Finishing the euchromatic sequence of the human genome. Nature 431:931-945.
17. Kreppel, F., V. Biermann, S. Kochanek, and G. Schiedner. 2002. A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations. Hum. Gene Ther. 13:1151-1156.
18. Kvittingen, E. A., H. Rootwelt, P. Brandtzaeg, A. Bergan, and R. Berger. 1993. Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect. J. Clin. Invest. 91:1816-1821.
19. Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J. P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, N. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J. C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R. H. Waterston, R. K. Wilson, L. W. Hillier, J. D. McPherson, M. A. Marra, E. R. Mardis, L. A. Fulton, A. T. Chinwalla, K. H. Pepin, W. R. Gish, S. L. Chissoe, M. C. Wendl, K. D. Delehaunty, T. L. Miner, A. Delehaunty, J. B. Kramer, L. L. Cook, R. S. Fulton, D. L. Johnson, P. J. Minx, S. W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J. F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921. (Pubitemid 32165345)
20. Laufs, S., K. Z. Nagy, F. A. Giordano, A. Hotz-Wagenblatt, W. J. Zeller, and S. Fruehauf. 2004. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns. Mol. Ther. 10:874-881.
21. Lehmann, E. L. 2006. Nonparametrics: statistical methods based on ranks. Springer, Berlin, Germany.
22. Lund, A. H., M. Duch, and F. S. Pedersen. 1996. Increased cloning efficiency by temperature-cycle ligation. Nucleic Acids Res. 24:800-801.
23. Miller, D. G., G. D. Trobridge, L. M. Petek, M. A. Jacobs, R. Kaul, and D. W. Russell. 2005. Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J. Virol. 79:11434-11442.
24. Mitchell, R. S., B. F. Beitzel, A. R. Schroder, P. Shinn, H. Chen, C. C. Berry, J. R. Ecker, and F. D. Bushman. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2:e234.
25. Montini, E., P. K. Held, M. Noll, N. Morcinek, M. Al-Dhalimy, M. Finegold, S. R. Yant, M. A. Kay, and M. Grompe. 2002. In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol. Ther. 6:759-769.
26. Nakai, H., E. Montini, S. Fuess, T. A. Storm, M. Grompe, and M. A. Kay. 2003. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34:297-302.
27. Nakai, H., X. Wu, S. Fuess, T. A. Storm, D. Munroe, E. Montini, S. M. Burgess, M. Grompe, and M. A. Kay. 2005. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J. Virol. 79:3606-3614.
28. Ohbayashi, F., M. A. Balamotis, A. Kishimoto, E. Aizawa, A. Diaz, P. Hasty, F. L. Graham, C. T. Caskey, and K. Mitani. 2005. Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors. Proc. Natl. Acad. Sci. U. S. A. 102:13628-13633.
29. Overturf, K., M. Al-Dhalimy, M. Finegold, and M. Grompe. 1999. The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. Am. J. Pathol. 155:2135-2143.
30. Overturf, K., M. al-Dhalimy, C. N. Ou, M. Finegold, R. Tanguay, A. Lieber, M. Kay, and M. Grompe. 1997. Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I. Hum. Gene Ther. 8:513-521.
31. Overturf, K., M. Al-Dhalimy, R. Tanguay, M. Brantly, C. N. Ou, M. Finegold, and M. Grompe. 1996. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat. Genet. 12:266-273.
32. Schiedner, G., F. Kreppel, and S. Kochanek. 2006. Production and quality control of high-capacity adenoviral vectors. In J. E. Celis (ed.), Cell biology: a laboratory handbook. Elsevier Academic Press, Burlington, MA.
33. Schirm, S., and W. Doerfler. 1981. Expression of viral DNA in adenovirus type 12-transformed cells, in tumor cells, and in revertants. J. Virol. 39:694-702.
34. Schulz, M., and W. Doerfler. 1984. Deletion of cellular DNA at site of viral DNA insertion in the adenovirus type 12-induced mouse tumor CBA-12-1-T. Nucleic Acids Res. 12:4959-4976.
35. Silver, J., and V. Keerikatte. 1989. Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus. J. Virol. 63:1924-1928.
36. Stephen, S. L., V. G. Sivanandam, and S. Kochanek. 2008. Homologous and heterologous recombination between adenovirus vector DNA and chromosomal DNA. J. Gene Med. 10:1176-1189.
37. Suzuki, K., K. Mitsui, E. Aizawa, K. Hasegawa, E. Kawase, T. Yamagishi, Y. Shimizu, H. Suemori, N. Nakatsuji, and K. Mitani. 2008. Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors. Proc. Natl. Acad. Sci. U. S. A. 105:13781-13786.
38. Tanguay, R. M., R. Jorquera, J. Poudrier, and M. St-Louis. 1996. Tyrosine and its catabolites: from disease to cancer. Acta Biochim. Pol. 43:209-216.
39. Triglia, T., M. G. Peterson, and D. J. Kemp. 1988. A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences. Nucleic Acids Res. 16:8186.
40. Trobridge, G. D., D. G. Miller, M. A. Jacobs, J. M. Allen, H. P. Kiem, R. Kaul, and D. W. Russell. 2006. Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. U. S. A. 103:1498-1503.
41. Volpers, C., and S. Kochanek. 2004. Adenoviral vectors for gene transfer and therapy. J. Gene Med. 6(Suppl. 1):S164-S171. (Pubitemid 40228025)
42. Wang, H., and A. Lieber. 2006. A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette. J. Virol. 80:11699-11709.
43. Wang, H., D. M. Shayakhmetov, T. Leege, M. Harkey, Q. Li, T. Papayannopoulou, G. Stamatoyannopolous, and A. Lieber. 2005. A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression. J. Virol. 79:10999-11013.
44. Wang, X., E. Montini, M. Al-Dhalimy, E. Lagasse, M. Finegold, and M. Grompe. 2002. Kinetics of liver repopulation after bone marrow transplantation. Am. J. Pathol. 161:565-574.
45. Wilson, Z. E., A. Rostami-Hodjegan, J. L. Burn, A. Tooley, J. Boyle, S. W. Ellis, and G. T. Tucker. 2003. Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver. Br. J. Clin. Pharmacol. 56:433-440.
46. Wu, X., Y. Li, B. Crise, and S. M. Burgess. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751.
47. Yant, S. R., X. Wu, Y. Huang, B. Garrison, S. M. Burgess, and M. A. Kay. 2005. High-resolution genome-wide mapping of transposon integration in mammals. Mol. Cell. Biol. 25:2085-2094.
48. Zhang, S., B. W. Glickman, and J. G. de Boer. 2001. Spontaneous mutation of the lacI transgene in rodents: absence of species, strain, and insertion-site influence. Environ. Mol. Mutagen. 37:141-146.